Abstract
BENZODIAZEPINES are widely prescribed anxiolytics and anti-convulsants which bind with high affinity to sites on the GABAA receptor/Cl– channel complex and potentiate the effect of the neurotransmitter GABA (γ-aminobutyric acid)1,2. The heterogeneity of benzodiazepine recognition sites in the central nervous system1,3,4 was revealed by studies showing different classes of GABAA receptor subunits (classes α, β and γ)5–7 and variant subunits in these classes, particularly in the α-class8–11. Expression of recombinant subunits produces functional receptors; when certain α-variants are coexpressed with β- and γ-subunits the resulting receptors have pharmacological properties characteristic of GABAA–benzodiazepine type I or type II receptors6,11,12. The α-variants are differentially expressed in the central nervous system13 and can be photoaffinity-labelled with benzodiazepines1,14,15. Here we report a novel α-subunit (α6) of cerebellar granule cells. We show that recombinant receptors composed of α6, β2 and γ2 subunits bind with high affinity to the GABA agonist [3H]muscimol and the benzodiazepine [3H]Rol5-4513 (refs 14,16) but not the other benzodiazepines or β-carbolines. The same distinctive pharmacology is observed with GABAA receptors from rat cerebellum immunoprecipitated by an antiserum specific for the α6 subunit. We conclude that this α-subunit is part of a cerebellar receptor subtype, selective for Rol5-4513 (ref. 17), an antagonist of alcohol-induced motor incoordination and ataxia18.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Olsen, R. W. & Venter, C. J. (eds) Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties (Liss, New York, 1986).
Möhler, H. & Okada, T. Science 198, 849–851 (1977).
Squires, R. F. et al. Pharmac. Biochem. Behavior 10, 825–830 (1979).
Sieghart, W. & Karobath, M. Nature 286, 285–287 (1980).
Schofield, P. et al. Nature 328, 221–227 (1987).
Pritchett, D. B. et al. Nature 338, 582–584 (1989).
Shivers, B. D. et al. Neuron 3, 327–337 (1989).
Levitan, E. et al. Nature 335, 76–79 (1988).
Ymer, S. et al. FEBS Lett. 258, 119–122 (1989).
Krestchatisky, M. et al. Neuron 3, 745–753 (1989).
Pritchett, D. B. & Seeburg, P. H. J. Neurochem. 54, 1802–1804 (1990).
Pritchett D. B., Lüddens, H. & Seeburg, P. H. Science 245, 1389–1392 (1989).
Wisden, W., Morris, B. J., Darlison, M. G., Hunt, S. P. & Barnard, E. A. Neuron 1, 937–947 (1988).
Sieghart, W., Eichinger, A., Richards, J. G. & Mohler, H. J. Neurochem. 48, 46–52 (1987).
Fuchs, K., Adamiker, D. & Sieghart, W. FEBS Lett. 261, 52–54 (1990).
Malminiemi, O. & Korpi, E. R. Eur. J. Pharm. 169, 53–60 (1989).
Uusi-Oukari, M. & Korpi, E. R. J. Neurochem. 54, 1980–1987 (1990).
Suzdak, P. D. et al. Science 234, 1243–1247 (1986).
Huganir, R. L. & Greengard, P. Trends Neurosci. 8, 472–477 (1986).
Duggan, M. J. & Stephenson, F. A. J. Neurochem. 53, 132–139 (1989).
Olsen, R. W., McCabe, R. T. & Wamsley, J. K. J. clin. Neuroanat. 3, 59–76 (1990).
Squires, R. F., Saederup, E., Damgaard, I. & Schousboe, A. J. Neurochem. 54, 473–478 (1990).
Lolait, S. J. et al. FEBS Lett. 246, 145–148 (1990).
Palacios, J. M., Wamsley, J. K. & Kuhar, M. J. Brain Res. 222, 285–307 (1981).
Unnerstall, J. R., Kuhar, M. J., Niehoff, D. L. & Palacios, J. M. J. Pharmac. exp. Ther. 218, 797–804 (1981).
McCabe, R. T. & Wamsley, J. K. Life Sci. 39, 1937–1945 (1986).
Towbin, H., Staehelin, T. & Gordon, J. Proc. natn. Acad. Sci. U.S.A. 76, 4350–4355 (1979).
Ewert, M. et al. J. Cell Biol. 110, 2043–2048 (1990).
von Heijne, G. Nucleic Acids Res. 14, 4683–4690 (1986).
Gorman, C. M., Gies, D. R. & McCray, G. DNA Prot engin. Tech. 2, 3–10 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lüddens, H., Pritchett, D., Köhler, M. et al. Cerebellar GABAA receptor selective for a behavioural alcohol antagonist. Nature 346, 648–651 (1990). https://doi.org/10.1038/346648a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/346648a0
This article is cited by
-
Anticonvulsive Activity in Audiogenic DBA/2 Mice of 1,4-Benzodiazepines and 1,5-Benzodiazepines with Different Activities at Cerebellar Granule Cell GABAA Receptors
Journal of Molecular Neuroscience (2016)
-
Study of the Interaction of 1,4- and 1,5-Benzodiazepines with GABAA Receptors of Rat Cerebellum Granule Cells in Culture
Journal of Molecular Neuroscience (2015)
-
GABAA Receptors of Cerebellar Granule Cells in Culture: Interaction with Benzodiazepines
Neurochemical Research (2013)
-
Pharmacological Properties of DOV 315,090, an ocinaplon metabolite
BMC Pharmacology (2008)
-
GABA A receptor alpha 6 subunit
AfCS-Nature Molecule Pages (2008)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.